Navigation Links
Medasense Receives Patent Approval for Novel Pain-Monitoring System
Date:8/20/2013

Tel Aviv, Israel (PRWEB) August 20, 2013

Medasense Biometrics Ltd. announced today it has received U.S. patent approval for its novel system and multi-parameter method of assessing the pain level of patients in various states of consciousness. (U.S. Patent No. 8,512,240 – “System and Method for Pain Monitoring Using a Multidimensional Analysis of Physiological Signals.”)

Medasense’s innovative technology enables non-invasive, objective, pain monitoring by measuring multiple pain-related physiological parameters. The data is then integrated using state-of-the-art signal processing and pattern recognition algorithms to identify a patient’s unique “signature of pain.” Using this information, physicians can adapt pain medications to patient-specific needs to reduce suffering and improve treatment outcomes.

“Pain is now widely considered the fifth vital sign,” says Galit Zuckerman, founder and CEO of Medasense. “Our easy-to-use system adds objective pain measurement to the array of technically advanced patient-monitoring tools already used in critical care, anesthesia and recovery, and similar environments.”

Medasense’s successfully completed clinical studies verify the system’s ability to accurately measure pain response and demonstrate that it outperforms all existing pain indicators. “Receiving this patent approval is a milestone achievement for the Medasense team,” says Zuckerman. “We look forward to providing physicians with a much better way to monitor and manage patient pain.”

About Medasense
Medasense Biometrics Ltd. is an early-stage medical device company specializing in innovative pain monitoring solutions. The company’s automated pain-monitoring system is designed to provide a continuous, highly accurate assessment of a patient’s pain level. Medasense is financed and supported by both private investors and by Medoc Ltd., a prominent manufacturer of pain diagnostic medical systems. For more information, visit: http://www.medasense.com/.

CONTACT:
Nir Ben Israel
Medasense Biometric Ltd.
info(at)medasense(dot)com
Tel. 972-4-9038800

Read the full story at http://www.prweb.com/releases/2013/8/prweb11038757.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. UCSB professor receives award for graphene electronics research
2. Watsons Generic Yaz(R) Receives FDA Approval
3. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
4. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
5. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
6. Intimate Bridge 2 Conception, Inc. Receives $4.3M
7. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
8. BioNeutral Group Receives $400,000 in Equity Financing
9. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
10. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
11. Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage of ... newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and ... synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):